Flow cytometry is a rapid method of cell counting and sorting, in some cases incorporating several characterization techniques such as mass spectrometry and fluorescence microscopy that can allow greater analysis to be undertaken in situ.
During flow cytometry cells are passed in single file to be analyzed individually, usually then categorized for further examination by other methods. Cell size, optical density, tenormin lupus morphology, granularity, and several other physical parameters that can be determined by light scattering can be used to infer the health of the cell, but the value of flow cytometry is significantly improved and expanded when incorporating other characterization techniques, amongst which the use of fluorophores in conjunction with fluorescence microscopy has proven extremely useful.
Image Credit: Jarun Ontakrai/Shutterstock.com
Biomarkers are molecules that can be used to quantitatively indicate the type and stage of a disease in a patient, allowing physicians to choose the best course of treatment. For example, the expression of estrogen receptor-alpha is a favorable prognostic factor in breast cancer patients, suggesting that patients will respond well to hormone therapy.
Biomarker discovery usually takes either a proteomic, metabolomic, lipidomic, or glycomic approach, focusing on analyzing the expression of proteins, all metabolites, lipids, or glycans, respectively, to uncover relationships between them and disease.
Several analytical methods are utilized in biomarker detection, involving collecting or culturing diseased cells or tissues and subsequently assessing the cell population for common abnormalities. Enzyme-linked immunosorbent assays are frequently used for this purpose, with the protein or other biomolecules of interest being tagged and allowing them to be quantitatively identified. However, this method is not able to distinguish between biomarkers produced by individual cells, while flow cytometry is capable of tracking multiple physical and biochemical parameters simultaneously in each cell.
Flow cytometry is extensively employed in cell sorting, allowing cells bearing features of interest to be separated and analyzed in greater detail, often undergoing detailed microscopy at the identification stage of biomarker discovery to determine the mechanism of disease. Researchers also employ flow cytometry to gather together rare cells that would otherwise be difficult to collect in abundance, such as stem cells.
Flow cytometry in diagnosis and prognosis
A variety of sample types can be utilized in flow cytometry, including whole blood, cell lines, tissues, and frozen peripheral blood cells, though the former is usually preferred to better represent the cell population in the blood.
Immunophenotyping is one common specific investigation undertaken using flow cytometry, allowing the identification of specific cell populations involved in disease progression and response to treatment. This is particularly useful in the diagnosis of various blood disorders such as leukemia and lymphoma, where numerous immune cell antigens can be identified simultaneously using fluorescent staining in whole blood samples. Similarly, the response to viral infection can be monitored in this way, where T- and B-cell populations can be quantified and cytokine expression measured.
The state of the cell cycle, cell proliferation, and apoptosis are often measured in flow cytometry using DNA-specific dyes such as annexin V or propidium iodide. Some of these dyes struggle to penetrate the intact cell membrane, and thus their intensity within the cell directly correlates to the state of degradation of the cell membrane and state of apoptosis. As cells in the G0 or G1 phases bear two copies of DNA they will also bear a greater concentration of dye within the nucleus.
Many drugs are dependent on cells being in a particular stage of the cell cycle to function, or otherwise may act by stalling the cell cycle at a particular stage, and thus this method can be used to determine the efficacy of a course of treatment. Similarly, resistance to apoptosis and uncontrolled proliferation are hallmarks of cancer, and thus assessing a cell's susceptibility to apoptosis and rate of proliferation is extremely useful to diagnosis, prognosis, and assessment of therapeutic measures.
- Mckinnon, K. M. (2021) Flow Cytometry: An Overview. Current protocols in immunology.
- Millan & Brunet (2015) Flow Cytometry as Platform for Biomarker Discovery and Clinical Validation. General Methods in Biomarker Research and their Applications.
- Alexander et al. (2009) Separating Stem Cells By Flow Cytometry: Reducing Variability for Solid Tissues. Cell stem cell.
- Colomer et al. (2018) Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clinical & translational oncology.
- All Flow Cytometry Content
- Using Flow Cytometry in Disease Diagnosis
- Flow Cytometry and Drug Discovery
- Flow Cytometry Methodology, Uses, and Data Analysis
- Flow Cytometry Techniques used in Medicine and Research
Last Updated: Nov 17, 2021
Michael graduated from Manchester Metropolitan University with a B.Sc. in Chemistry in 2014, where he majored in organic, inorganic, physical and analytical chemistry. He is currently completing a Ph.D. on the design and production of gold nanoparticles able to act as multimodal anticancer agents, being both drug delivery platforms and radiation dose enhancers.
Source: Read Full Article